Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 4.94M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -7.62M | Forward P/E | -0.53 | EPS next Y | - | 50D Avg Chg | -8.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -61.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -89.00% |
| Recommedations | - | Quick Ratio | 3.98 | Shares Outstanding | 3.65M | 52W Low Chg | 5.00% |
| Insider Own | 20.02% | ROA | -30.89% | Shares Float | 2.72M | Beta | 2.37 |
| Inst Own | 10.69% | ROE | - | Shares Shorted/Prior | 4.88K/4.83K | Price | 1.36 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 161,104 | Target Price | 39.00 |
| Oper. Margin | - | Earnings Date | - | Volume | 23,845 | Change | -2.16% |
About BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.